Overview
This book is an overview of current progress in drug design. It focuses on energetics of drug interactions with solvents and biomolecules, applications of traditional drug design methods, and related evolutionary algorithms.
Full Product Details
Author: Abby L. Parrill (Professor of Chemistry, Professor of Chemistry, Michigan State University) ,
M. Rami Reddy (Director of Computational Chemistry and Information Technology, Director of Computational Chemistry and Information Technology, Metabasis Therapeutic, Inc.)
Publisher: American Chemical Society
Imprint: American Chemical Society
Volume: 719
Dimensions:
Width: 16.00cm
, Height: 2.30cm
, Length: 23.60cm
Weight: 0.662kg
ISBN: 9780841236035
ISBN 10: 0841236038
Pages: 368
Publication Date: 01 April 1999
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: No Longer Our Product
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Reviews
Papers from a September 1997 symposium reflect a broad spectrum of current topics in rational drug design. Contributors come from diverse work environments where research in rational drug design takes place, including the pharmaceutical industry, software development industry, and academia. Early chapters overview rational drug design and provide an explanation for many topics that occur in later chapters. Later chapters discuss more detailed aspects of energetics and solvation, describe applications of drug design methods, detail new methods for QSAR and combinatorial chemistry, and review evolutionary algorithms in drug design. For computational chemists and researchers in rational drug or materials design. The editors are associated with the University of Memphis and Metabasis Therapeutics, Inc.--SciTech Book News
<br> Papers from a September 1997 symposium reflect a broad spectrum of current topics in rational drug design. Contributors come from diverse work environments where research in rational drug design takes place, including the pharmaceutical industry, software development industry, and academia. Early chapters overview rational drug design and provide an explanation for many topics that occur in later chapters. Later chapters discuss more detailed aspects of energetics and solvation, describe applications of drug design methods, detail new methods for QSAR and combinatorial chemistry, and review evolutionary algorithms in drug design. For computational chemists and researchers in rational drug or materials design. The editors are associated with the University of Memphis and Metabasis Therapeutics, Inc. --SciTech Book News<p><br>
Papers from a September 1997 symposium reflect a broad spectrum of current topics in rational drug design. Contributors come from diverse work environments where research in rational drug design takes place, including the pharmaceutical industry, software development industry, and academia. Early chapters overview rational drug design and provide an explanation for many topics that occur in later chapters. Later chapters discuss more detailed aspects of energetics and solvation, describe applications of drug design methods, detail new methods for QSAR and combinatorial chemistry, and review evolutionary algorithms in drug design. For computational chemists and researchers in rational drug or materials design. The editors are associated with the University of Memphis and Metabasis Therapeutics, Inc. --SciTech Book News<br>
